Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
European Journal of Nuclear Medicine and Molecular Imaging|January 29, 2010
In vitro experimental (211)At-anti-CD33 antibody therapy of leukaemia cells overcomes cellular resistance seen in vivo against gemtuzumab ozogamicinThorsten Petrich, Zekiye Korkmaz, Doris Krull, et al.Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|February 9, 2010
Synthesis and analysis of 2-[211At]-L-phenylalanine and 4-[211At]-L-phenylalanine and their uptake in human glioma cell cultures in-vitroGeerd J Meyer, Almut Walte, Siva R Sriyapureddy, et al.Neuroscience Letters|June 7, 2005
Serotonin transporter binding in Tourette SyndromeKirsten R Müller-Vahl, Geerd J Meyer, Wolfram H Knapp, et al.Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|August 28, 2007
Preparation and evaluation of 211At labelled antineoplastic antibodiesAlmut Walte, Siva Sankar Reddy Sriyapureddy, Zekiye Korkmaz, et al.Anesthesia and Analgesia|November 14, 2009
The first scintigraphic detection of tumor necrosis factor-alpha in patients with complex regional pain syndrome type 1Michael Bernateck, Matthias Karst, Klaus F Gratz, et al.European Journal of Nuclear Medicine and Molecular Imaging|December 17, 2002
[N-methyl 11C]meta-Hydroxyephedrine positron emission tomography in Parkinson's disease and multiple system atrophyGeorg Berding, Christoph H Schrader, Thomas Peschel, et al.Neurological Research|October 28, 2008
Modified calcium accumulation after controlled cortical impact under cyclosporin A treatment: a 45Ca autoradiographic studyM Javad Mirzayan, Petra M Klinge, Sven Ude, et al.Plos One|June 6, 2015
Positron Emission Tomography Imaging Reveals Auditory and Frontal Cortical Regions Involved with Speech Perception and Loudness AdaptationGeorg Berding, Florian Wilke, Thilo Rode, et al.European Journal of Nuclear Medicine and Molecular Imaging|April 12, 2008
The potential of 211Astatine for NIS-mediated radionuclide therapy in prostate cancerMichael J Willhauck, Bibi-Rana Sharif Samani, Ingo Wolf, et al.Pageof 1